Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Liver cancer resists most chemo drugs. The liver cancer drugs that have been most effective as systemic chemo in liver cancer are doxorubicin (Adriamycin), 5-fluorouracil, and cisplatin. But even these drugs shrink only a small portion of tumors, and the responses often do not last long.
The report details the trend, potential and market size of Liver Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liver Cancer Drugsmarket, defines the market attractiveness level of Liver Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liver Cancer Drugs industry, describes the types of Liver Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liver Cancer Drugs market and the development prospects and opportunities of Liver Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liver Cancer Drugs market in Chapter 13.
By Player:
Bayer
Bristol-Myers Squibb
Merck
Eisai
Exelixis
By Type:
Targeted Therapy
Immunotherapy
By End-User:
Hospital
Home
Research
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liver Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liver Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liver Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liver Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liver Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Liver Cancer Drugs Consumption (2017-2022)
-
7.2 United States Liver Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Liver Cancer Drugs Consumption (2017-2022)
-
7.4 China Liver Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Liver Cancer Drugs Consumption (2017-2022)
-
7.6 India Liver Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Liver Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Liver Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Liver Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Liver Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Liver Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Liver Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Liver Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Liver Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Liver Cancer Drugs Consumption Forecast (2022-2028)
9 Global Liver Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Liver Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Liver Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Home Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Consumption and Growth Rate (2017-2022)
10 Global Liver Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Liver Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liver Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Home Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Consumption Forecast and Growth Rate (2022-2028)
11 Global Liver Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liver Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liver Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liver Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liver Cancer Drugs Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Liver Cancer Drugs Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Liver Cancer Drugs Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Liver Cancer Drugs Product and Service
-
14.4 Eisai
-
14.4.1 Eisai Company Details
-
14.4.2 Eisai Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Liver Cancer Drugs Product and Service
-
14.5 Exelixis
-
14.5.1 Exelixis Company Details
-
14.5.2 Exelixis Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Exelixis Liver Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liver Cancer Drugs
-
Figure Liver Cancer Drugs Picture
-
Table Global Liver Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liver Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Liver Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Liver Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Liver Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Liver Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Liver Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liver Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Liver Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liver Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liver Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liver Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liver Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liver Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Home Consumption and Growth Rate (2017-2022)
-
Figure Global Research Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liver Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liver Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Liver Cancer Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Liver Cancer Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Liver Cancer Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Liver Cancer Drugs Product and Service
-
Table Exelixis (Foundation Year, Company Profile and etc.)
-
Table Exelixis Liver Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Liver Cancer Drugs Product and Service
-
